124 related articles for article (PubMed ID: 32768561)
1. Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates.
Tom MC; Sittenfeld SMC; Shah C; Bauer-Nilsen K; Tendulkar R; Cherian S; Al-Hilli Z; Arthur D; Recht A; Vicini F
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):273-280. PubMed ID: 32768561
[TBL] [Abstract][Full Text] [Related]
2. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
[TBL] [Abstract][Full Text] [Related]
3. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
Olivotto IA; Link E; Phillips C; Whelan TJ; Bryant G; Kunkler IH; Westenberg AH; Purohit K; Ahern V; Graham PH; Akra M; McArdle O; Ludbrook JJ; Harvey JA; Maduro JH; Kirkove C; Gruber G; Martin JD; Campbell ID; Delaney GP; Chua BH;
Radiother Oncol; 2020 Jan; 142():180-185. PubMed ID: 31431385
[TBL] [Abstract][Full Text] [Related]
4. Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: A randomized non-inferiority clinical trial.
Fadavi P; Nafissi N; Mahdavi SR; Jafarnejadi B; Javadinia SA
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1376. PubMed ID: 33797199
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
6. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality Consortium.
Dilworth JT; Griffith KA; Pierce LJ; Jagsi R; Quinn TJ; Walker EM; Radawski JD; Dominello MM; Gustafson GS; Moran JM; Hayman JA; Vicini FA
Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):266-277. PubMed ID: 35157997
[TBL] [Abstract][Full Text] [Related]
8. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M;
Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Hypofractionated Whole Breast Irradiation in Early Stage, Biologically High-Risk Breast Cancer.
Willen BD; Quinn TJ; Almahariq MF; Chen PY; Jawad MS; Gustafson GS; Leung E; Wu MKY; Dilworth JT
Pract Radiat Oncol; 2022; 12(6):e501-e511. PubMed ID: 35724921
[TBL] [Abstract][Full Text] [Related]
10. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner G; Reitsamer R; Urbański B; Kopp P; Murawa D; Adamczyk B; Karzcewska A; Milecki P; Hager E; Reiland J; Ciabattoni A; Matuschek C; Budach W; Nowell K; Schumacher C; Ricke A; Fusco V; Vidali C; Alessandro M; Ivaldi GB; Ziegler I; Fussl C; Zehentmayr F; Grambozov B; Sir A; Hitzl W; Ricardi U; Sedlmayer F
Radiother Oncol; 2020 May; 146():136-142. PubMed ID: 32151790
[TBL] [Abstract][Full Text] [Related]
12. Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features.
Lee SW; Shin KH; Chie EK; Kim JH; Im SA; Han W; Noh DY; Lim HW; Kim TH; Lee KS; Lee ES; Sung SY; Kim K
Oncotarget; 2016 Dec; 7(49):81888-81898. PubMed ID: 27588485
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
[TBL] [Abstract][Full Text] [Related]
15. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
16. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
[TBL] [Abstract][Full Text] [Related]
17. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
Haque W; Verma V; Haque A; Butler EB; Teh BS
Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
[TBL] [Abstract][Full Text] [Related]
18. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
[TBL] [Abstract][Full Text] [Related]
20. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
Rosenberger LH; Mamtani A; Fuzesi S; Stempel M; Eaton A; Morrow M; Gemignani ML
Ann Surg Oncol; 2016 Oct; 23(10):3239-46. PubMed ID: 27411549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
